Momentum mover BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is down 8% in pre-open action after ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE